Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study - Estevez, L G; Sanchez-Rovira, P; Domine, M; Leon, A; Calvo, I; Jaen, A; Casado, V; Rubio, G; Diaz, M; Miro, C; Lobo, F; Carrasco, E; et al. (Clinical & Translational Oncology, 2007)